Pain Management

Pharmacists can help patients by recommending the most effective and safest therapies.

All 3 are essential in the fight against the opioid crisis, but they need to forge alliances and work together.

Analgesic Alternatives May Help Reduce Unnecessary Exposure to Opioid Medications

Calcitonin gene-related peptide inhibitors are integral to preventing these powerful headaches.

Because of potential adverse reactions, careful product selection for both acute injuries and chronic conditions is key.

This month's case studies include a potential drug-related problem and a possible overdose.

Pharmacists can guide patients in the appropriate and safe use of these products and direct them to seek medical care when warranted.

Brown bagging is an essential educational and safety tool for patients who are suffering.

This method may optimize pain control and could be an answer to the opioid crisis.

The results of a study of almost 500,000 women indicate that taking paracetamol or other painkillers during pregnancy does not increase the risk of asthma in children.

Drug overdoses involving opioids have increased, and naloxone can be a life-saving drug to prevent deaths.

The opioid epidemic has become widespread throughout the country, and it is considered a top public health priority.

"It drives me crazy when a patient says, 'I know you are not a doctor, but what do you recommend for knee pain?'"

Larry Schieber, RPh, pharmacist and owner of Shieber Pharmacy in Circleville, OH discusses his pharmacist's recent initiative to distribute naloxone to local law enforcement at the 2019 Cardinal Health Retail Business Conference in Nashville, TN.

The partnership with Google in just 1 of the initiatives that Rite Aid has implemented as part of its comprehensive strategy to address prescription drug misuse and drug use disorders.

Specific types of cancer—such as bone, kidney, throat, and uterine—also had a higher incidence of chronic and severe pain that restricted daily activity.

Pharmacists are part of collaborative care models for opioid use disorder (OUD) treatment and suicide prevention.

Hospital pharmacists are encouraged to play a larger role for improving patient outcomes.

NKTR-181 is currently under review with the FDA, with a Prescription Drug User Fee Act (PDUFA) target action expected in August 2019.

The 17% drop is the biggest ever recorded in the United States market, according to the IQVIA Institute for Human Data Science.

Although these chemotherapy agents provide convenience and ease, they are subject to hepatic first-pass metabolism and enzymatic drug-drug interactions.

The CBD-related items include non-THC containing topical creams, patches and sprays.

Some patients are hesitant to use this class of drugs because of the stigma of potential addiction.

Health care providers should use the treat-to-target approach to achieve the best outcomes for rheumatoid arthritis patients.

Focusing on the criminal operations of criminal dispensers and prescribers can end in conviction.